Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SIRT”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04362436
What this trial is testing

TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets

Who this might be right for
Neuroendocrine TumorsLiver Metastases
Imperial College London 24
Testing effectiveness (Phase 2)WithdrawnNCT00654667
What this trial is testing

Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome

Who this might be right for
Insulin Resistance
University of California, San Francisco
Testing effectiveness (Phase 2)UnknownNCT00408551
What this trial is testing

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Goshen Health System 20
Not applicableStudy completedNCT05662475
What this trial is testing

Effect of Periodontal Treatment on Visfatin, fetuin-a and Sirtuin 1 of Patients With Periodontitis and Type 2 Diabetes

Who this might be right for
Periodontal DiseasesType 2 DiabetesPeriodontitis
Ondokuz Mayıs University 66
Not applicableUnknownNCT05742373
What this trial is testing

Role of Fasted Exercise on Improving Cardiometabolic Health

Who this might be right for
Cardiovascular DiseasesDiabetes Mellitus, Type 2Obesity
Manchester Metropolitan University 30
Not applicableLooking for participantsNCT05967143
What this trial is testing

Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)Liver Metastases From Colorectal Cancer (mCRC)
Sirtex Medical 845
Testing effectiveness (Phase 2)Looking for participantsNCT05655949
What this trial is testing

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Who this might be right for
Bile Duct CancerCholangiocarcinomaCholangiocarcinoma Non-resectable+2 more
Beth Israel Deaconess Medical Center 30
Not applicableLooking for participantsNCT07070076
What this trial is testing

A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Li Qiang 286
Not applicableEnded earlyNCT05451862
What this trial is testing

Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Terumo Europe N.V. 6
Testing effectiveness (Phase 2)Ended earlyNCT01686880
What this trial is testing

Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Jules Bordet Institute 10
Post-approval studies (Phase 4)Study completedNCT01798160
What this trial is testing

Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).

Who this might be right for
Hepatocellular Carcinoma
Johannes Gutenberg University Mainz 24
Very early researchNot Yet RecruitingNCT07712770
What this trial is testing

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

Who this might be right for
Recurrent Glioblastoma IDH WildtypeRecurrent Glioblastoma
Olivia Newton-John Cancer Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT02582034
What this trial is testing

Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry

Who this might be right for
Adenoma, Liver Cell
Center Eugene Marquis 56
Not applicableLooking for participantsNCT06999174
What this trial is testing

Multiparametric MRI for Characterization of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
University Hospital Muenster 128
Testing effectiveness (Phase 2)UnknownNCT04659382
What this trial is testing

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerpMMRMSS+2 more
Federation Francophone de Cancerologie Digestive 52
Not applicableStudy completedNCT02132091
What this trial is testing

Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress

Who this might be right for
AgingMetabolism
University of Florida 37
Not applicableStudy completedNCT05183776
What this trial is testing

Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT

Who this might be right for
Liver CancerLiver Metastasis Colon CancerPrimary Liver Cancer
Radboud University Medical Center 5
Not applicableUnknownNCT03292991
What this trial is testing

REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN)

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan 100
Post-approval studies (Phase 4)UnknownNCT02011906
What this trial is testing

The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients

Who this might be right for
Coronary Artery Disease
Tehran University of Medical Sciences 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04522544
What this trial is testing

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Next Page